Esbriet 267mg Hard Capsule 270s (Bottle)

Esbriet 267mg Hard Capsule 270s (Bottle) is a medication belonging to the drug class known as antifibrotic agents. It is used for the treatment of a specific lung disease called idiopathic pulmonary fibrosis (IPF). Esbriet 267mg Hard Capsule 270s (Bottle) works by reducing the progression of fibrosis in the lungs, helping to improve breathing and quality of life in patients with IPF. Some common side effects of Esbriet 267mg Hard Capsule 270s (Bottle) include gastrointestinal symptoms such as nausea, diarrhea, and vomiting. Patients should be aware that this medication may cause sensitivity to sunlight and they should use sun protection measures. It is important to discuss any other medications or medical conditions with your healthcare provider before starting Esbriet 267mg Hard Capsule 270s (Bottle).

Esbriet 267mg Hard Capsule 270s (Bottle) is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease characterized by the development of scar tissue in the lungs. Esbriet 267mg Hard Capsule 270s (Bottle) works by slowing down the progression of fibrosis, improving lung function, and reducing the symptoms associated with IPF.

Esbriet 267mg Hard Capsule 270s (Bottle) should be taken exactly as prescribed by your healthcare provider. The capsules should be swallowed whole with water and should not be crushed, chewed, or opened. It is recommended to take Esbriet 267mg Hard Capsule 270s (Bottle) with food to help minimize gastrointestinal side effects. Follow the dosing schedule provided by your healthcare provider and do not exceed the recommended dose.

The recommended dosage of Esbriet 267mg Hard Capsule 270s (Bottle) is one 267mg hard capsule three times a day, with meals. The total daily dose should not exceed 801mg. Your healthcare provider will determine the appropriate duration of treatment based on your individual response.

The shelf life of Esbriet 267mg Hard Capsule 270s (Bottle) is typically 3 years from the date of manufacture. Please check the packaging for the exact expiration date and do not use the medication beyond this date.

Esbriet 267mg Hard Capsule 270s (Bottle) should be stored at room temperature, between 20°C and 25°C (68°F and 77°F), in a tightly closed container. Avoid exposure to moisture, heat, or direct sunlight. Keep out of reach of children.

• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Loss of appetite
• Weight loss
• Headache
• Dizziness
• Fatigue
• Increased sensitivity to sunlight (photosensitivity)
• Skin rash

Esbriet 267mg Hard Capsule 270s (Bottle) is contraindicated in patients who are hypersensitive to the active ingredient tacrolimus or other ingredients in the formulation. It should also not be used in patients with uncontrolled high blood pressure, history of malignancy, or those who are pregnant or breastfeeding.

Esbriet 267mg Hard Capsule 270s (Bottle) may interact with certain medications, such as strong inhibitors or inducers of CYP1A2 and CYP3A4 enzymes, which can affect the metabolism of Esbriet 267mg Hard Capsule 270s (Bottle). It is important to inform your healthcare provider about all the medications, including over-the-counter drugs and herbal supplements, that you are taking. Avoid consuming grapefruit or grapefruit juice while taking Esbriet 267mg Hard Capsule 270s (Bottle), as it may increase drug levels in the blood.

• Take Esbriet 267mg Hard Capsule 270s (Bottle) with food to reduce stomach upset.
• Use sun protection measures, such as sunscreen and protective clothing, as Esbriet 267mg Hard Capsule 270s (Bottle) may cause increased sensitivity to sunlight.
• Follow your healthcare provider's instructions regarding the dosing schedule and duration of treatment.
• Inform your healthcare provider about all other medications and medical conditions before starting Esbriet 267mg Hard Capsule 270s (Bottle).

1. Can I take Esbriet 267mg Hard Capsule 270s (Bottle) with other medications?
   It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and herbal supplements, to avoid any potential drug interactions with Esbriet 267mg Hard Capsule 270s (Bottle).

2. How long do I need to take Esbriet 267mg Hard Capsule 270s (Bottle) for?
   The duration of treatment with Esbriet 267mg Hard Capsule 270s (Bottle) will be determined by your healthcare provider based on your individual response and the progression of your idiopathic pulmonary fibrosis (IPF). It is important to follow your healthcare provider's instructions regarding the duration of treatment.

3. Can I drink alcohol while taking Esbriet 267mg Hard Capsule 270s (Bottle)?
   It is generally recommended to avoid or limit alcohol consumption while taking Esbriet 267mg Hard Capsule 270s (Bottle), as alcohol may increase the risk of liver toxicity. It is best to consult with your healthcare provider regarding alcohol consumption while on Esbriet 267mg Hard Capsule 270s (Bottle) treatment.